CADL - Krystal Biotech Candel Edgewise gain after FDA fast track tags
2024-02-13 08:37:05 ET
More on Candel, Edgewise, etc.
- Edgewise: DMD Data In The First Half Of 2024 Could Lead To Additional Testing
- Krystal Biotech's Vyjuvek Impresses Early On, Bolsters Prospects
- Krystal Biotech added to Evercore’s Tactical Outperform list on drug launch
- Candel shares surge as pancreatic cancer candidate gets FDA fast track status
- Seeking Alpha’s Quant Rating on Candel Therapeutics